Abstract
We treated 304 patients with Thermex II hyperthermia system. The prostate was heated transurethrally to 44,5 ° C with the treatment consisting of 1 session of 180 minutes. Follow up ranged from 1 to 7 months. Significant improvement include increased mean urine flow rate and maximum urine flow rate (p<0,0001). We observed for the symptomatic benign prostatic hypeı-plasia group; better response (% 50,5), good response (% 42,1), prostatic resection (% 7,3). We noted for the urinary retention group with the indweiling catheters; free from the catheter (% 61,9), continue with catheter (% 20,9), prostatic resection (% 17,1). Toxicity was mild and consisted of hematuria (% 30), bladder spasms (% 26), heating sensation (% 19), perineal pain requiring analgesics during treatment (% 15). Transurethral hyperthermia represents a safe and promising outpatient approach to the treatment of benign prostatic hyperplasia, particularly for patients who are not candidate for conventional surgical approaches because of medical or personal reasons.
Keywords: Hyperthermia, Prostate, Hyperplasia
